METHODS COMPRISING CONTINUOUS ADMINISTRATION OF A GLP-1 RECEPTOR AGONIST AND CO-ADMINSTRATION OF A DRUG

Provided is a method for administering to a subject, via an implantable delivery device, a continuous subcutaneous dose of glucagon-like peptide-1 (GLP-1) analog, wherein the subject is orally co-administered with a drug after implantation of the implantable delivery device and during continuous sub...

Full description

Saved in:
Bibliographic Details
Main Authors BARON MICHELLE, YOUNG ANDREW
Format Patent
LanguageChinese
English
Published 10.09.2019
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided is a method for administering to a subject, via an implantable delivery device, a continuous subcutaneous dose of glucagon-like peptide-1 (GLP-1) analog, wherein the subject is orally co-administered with a drug after implantation of the implantable delivery device and during continuous subcutaneous dosing of the GLP-1 analog. 提供了一种通过植入式递送装置向受试者施用连续皮下剂量的胰高血糖素样肽-1(GLP-1)类似物的方法，其中所述受试者在所述植入式递送装置植入之后并且在连续皮下给药所述GLP-1类似物期间通过口服共同施用药物。
Bibliography:Application Number: CN20188005825